JPH06506677A - 脳水腫の治療のためのトラセミドの使用 - Google Patents
脳水腫の治療のためのトラセミドの使用Info
- Publication number
- JPH06506677A JPH06506677A JP4508486A JP50848692A JPH06506677A JP H06506677 A JPH06506677 A JP H06506677A JP 4508486 A JP4508486 A JP 4508486A JP 50848692 A JP50848692 A JP 50848692A JP H06506677 A JPH06506677 A JP H06506677A
- Authority
- JP
- Japan
- Prior art keywords
- torasemide
- cerebral edema
- treatment
- experimental
- time
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (4)
- 1.4−3′−メチルフェニルアミノピリジン−3−スルホンアミドまたはその 薬理学的に許容される塩の脳水腫治療のための使用。
- 2.激しい頭骨脳外傷、脳局所貧血、発作、転移または癲癇性発作の結果として 生じる脳水腫の治療のための請求項1の使用。
- 3.低浸透過水分過剰により開始される細胞毒脳水腫の治療のための、請求項1 記載の使用。
- 4.活性物質を通常のキャリヤーおよび補助物質の他に5乃至40mgの重量で 含むことを特徴とする、経口的または非経口的に投与可能な4−3′−メチルフ ェニルアミノピリジン−3−スルホンアミド。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4113820.1 | 1991-04-27 | ||
DE4113820A DE4113820A1 (de) | 1991-04-27 | 1991-04-27 | Verwendung von torasemid zur behandlung von hirnoedemen |
PCT/EP1992/000884 WO1992019245A1 (de) | 1991-04-27 | 1992-04-22 | Verwendung von torasemid zur behandlung von hirnödemen |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH06506677A true JPH06506677A (ja) | 1994-07-28 |
JP3429507B2 JP3429507B2 (ja) | 2003-07-22 |
Family
ID=6430498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP50848692A Expired - Lifetime JP3429507B2 (ja) | 1991-04-27 | 1992-04-22 | 脳水腫の治療のためのトラセミドの使用 |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0583280B1 (ja) |
JP (1) | JP3429507B2 (ja) |
AT (1) | ATE141053T1 (ja) |
AU (1) | AU1669092A (ja) |
CA (1) | CA2108794C (ja) |
DE (2) | DE4113820A1 (ja) |
ES (1) | ES2093257T3 (ja) |
WO (1) | WO1992019245A1 (ja) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE102008000737A1 (de) | 2008-03-18 | 2009-09-24 | Robert Bosch Gmbh | Handwerkzeugmaschine, insbesondere handgeführte Schleifmaschine |
US9241933B2 (en) | 2011-03-01 | 2016-01-26 | Pharnext | Compositions for treating amyotrophic lateral sclerosis |
US10010515B2 (en) | 2011-03-01 | 2018-07-03 | Pharnext | Therapeutic approaches for treating Parkinson's disease |
UA113165C2 (xx) * | 2011-03-01 | 2016-12-26 | Застосування комбінації баклофену і акампросату для лікування неврологічних захворювань та композиція, яка містить баклофен і акампросат | |
US9867837B2 (en) | 2011-03-01 | 2018-01-16 | Pharnext | Compositions for treating neurological disorders |
US9248111B2 (en) | 2011-03-01 | 2016-02-02 | Pharnext | Therapeutic approaches for treating parkinson's disease |
US9931326B2 (en) | 2011-03-29 | 2018-04-03 | Pharnext | Composition comprising torasemide and baclofen for treating neurological disorders |
CN109512805B (zh) | 2012-05-08 | 2021-12-31 | 埃罗米克斯公司 | 用于治疗水通道蛋白介导的疾病的化合物 |
JP6535338B2 (ja) | 2013-11-06 | 2019-06-26 | エアロミクス・インコーポレイテッドAeromics,Inc. | 新規製剤 |
CN110054647B (zh) * | 2019-05-23 | 2021-06-15 | 上海勋和医药科技有限公司 | 托拉塞米磷酸酯类前药、其制备方法及组合物 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8809205D0 (en) * | 1988-04-19 | 1988-05-25 | Nye P C G | Treatment of oedema |
-
1991
- 1991-04-27 DE DE4113820A patent/DE4113820A1/de not_active Withdrawn
-
1992
- 1992-04-22 WO PCT/EP1992/000884 patent/WO1992019245A1/de active IP Right Grant
- 1992-04-22 AU AU16690/92A patent/AU1669092A/en not_active Abandoned
- 1992-04-22 EP EP92909055A patent/EP0583280B1/de not_active Expired - Lifetime
- 1992-04-22 ES ES92909055T patent/ES2093257T3/es not_active Expired - Lifetime
- 1992-04-22 AT AT92909055T patent/ATE141053T1/de active
- 1992-04-22 DE DE59206872T patent/DE59206872D1/de not_active Expired - Lifetime
- 1992-04-22 CA CA002108794A patent/CA2108794C/en not_active Expired - Lifetime
- 1992-04-22 JP JP50848692A patent/JP3429507B2/ja not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE141053T1 (de) | 1996-08-15 |
ES2093257T3 (es) | 1996-12-16 |
AU1669092A (en) | 1992-12-21 |
CA2108794C (en) | 2003-06-24 |
DE59206872D1 (de) | 1996-09-12 |
DE4113820A1 (de) | 1992-10-29 |
JP3429507B2 (ja) | 2003-07-22 |
WO1992019245A1 (de) | 1992-11-12 |
CA2108794A1 (en) | 1992-10-28 |
EP0583280B1 (de) | 1996-08-07 |
EP0583280A1 (de) | 1994-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bakris et al. | Effects of theophylline on erythropoietin production in normal subjects and in patients with erythrocytosis after renal transplantation | |
Kahn et al. | Massive blood replacement: Correlation of ionized calcium, citrate, and hydrogen ion concentration | |
Nakagomi et al. | Effect of cyclooxygenase and lipoxygenase inhibitors on delayed neuronal death in the gerbil hippocampus. | |
Feigen et al. | Differential effects of ibuprofen and indomethacin in the regional circulation of the dog. | |
Alward et al. | Effects of asphyxia on cardiac output and organ blood flow in the newborn piglet | |
JPH06506677A (ja) | 脳水腫の治療のためのトラセミドの使用 | |
US5486530A (en) | Use of torasemide for the treatment of brain oedemas | |
RU2391979C2 (ru) | ДИГИДРОБРОМИД 2-(3,4-ДИГИДРОКСИФЕНИЛ)-9-ДИЭТИЛАМИНОЭТИЛИМИДАЗО[1,2-a] БЕНЗИМИДАЗОЛА И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ НА ЕГО ОСНОВЕ | |
Reyes et al. | Role of the 5-lipooxygenase pathway in obstructive nephropathy | |
JPH01100118A (ja) | ホスホジエステラーゼ阻害剤及びトロンボキサンa↓2拮抗剤を含む新規な医薬組成物、その使用及びその製造法 | |
Schulert et al. | The physiologic disposition of phenylindanedione in man | |
JP2720348B2 (ja) | 脳細胞機能障害改善剤 | |
NZ331811A (en) | Method of treating or preventing interstitial cystitis using duloxetine | |
Bocking et al. | Increased uteroplacental production of prostaglandin E2 during ethanol infusion | |
Cairns et al. | Prazosin treatment complicated by acute febrile polyarthritis. | |
Hastwell et al. | THE EFFECT OF ORAL SALBUTAMOL ON SERUM POTASSIUMAND BLOOD SUGAR | |
EP1581227B1 (en) | A method for treating renal failure | |
Lee et al. | Effect of D-tubocurarine and anaesthesia upon cardiac output in normal and histamine-depleted dogs | |
JPH01131113A (ja) | 脳障害治療剤 | |
Nally et al. | The acute effect of lithium on renal renin and prostaglandin E synthesis in the dog. | |
Murdock et al. | Inotropic effects of ionic contrast media: the role of calcium binding additives | |
JPH05504130A (ja) | 腫瘍壊死因子拮抗剤 | |
CN115300501B (zh) | Tpt-260在制备用于治疗脑卒中的药物中的应用 | |
Seedat, YK, Hoosen, S. & Bhigjee | Reserpine plus hydrochlorothiazide and sotalol plus hydrochlorothiazide in black and Indian hypertensive patients | |
Ephgrave et al. | The role of platelet-activating factor in conscious, normotensive endotoxemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090516 Year of fee payment: 6 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090516 Year of fee payment: 6 |
|
S111 | Request for change of ownership or part of ownership |
Free format text: JAPANESE INTERMEDIATE CODE: R313113 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100516 Year of fee payment: 7 |
|
R350 | Written notification of registration of transfer |
Free format text: JAPANESE INTERMEDIATE CODE: R350 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100516 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100516 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100516 Year of fee payment: 7 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110516 Year of fee payment: 8 |
|
FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20120516 Year of fee payment: 9 |
|
EXPY | Cancellation because of completion of term |